Fluorescein
Sponsors
Bayer AG, Astellas Pharma Global Development Inc., University of Utah, Stanford University, Anandasabapathy, Sharmila, M.D.
Conditions
Adenomatous PolypsAerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility InvestigationsAnaplastic AstrocytomaBarrett's EsophagusBrain CancerBrain NeoplasmsBreast CancerCancer
Early Phase 1
A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
TerminatedNCT01384695
Start: 2009-06-30End: 2014-02-28Updated: 2016-01-12
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
CompletedNCT01979003
Start: 2014-09-30End: 2021-06-30Updated: 2022-02-24
Phase 1
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma
CompletedNCT00847522
Start: 2009-02-28End: 2016-07-31Updated: 2017-12-20
Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer
WithdrawnNCT01614184
Start: 2008-05-31End: 2013-06-30Updated: 2013-07-10
Phase 2
Phase 3
A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)
CompletedNCT05850520
Start: 2023-05-15End: 2025-05-27Updated: 2025-12-18
(22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion
CompletedCTIS2022-502174-16-00
Start: 2023-09-13End: 2025-05-14Target: 255Updated: 2025-06-02
AN OPEN-LABEL EXTENSION (OLE) PHASE 3 TRIAL TO ASSESS THE SAFETY OF INTRAVITREAL ADMINISTRATION OF AVACINCAPTAD PEGOL (COMPLEMENT C5 INHIBITOR) IN PATIENTS WITH GEOGRAPHIC ATROPHY WHO PREVIOUSLY COMPLETED PHASE 3 STUDY ISEE2008 (GATHER2)
CompletedCTIS2024-515185-13-00
Start: 2022-12-21End: 2025-04-10Target: 126Updated: 2025-03-21
Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED)
Not yet recruitingNCT07356349
Start: 2026-01-15End: 2026-12-31Target: 114Updated: 2026-01-23
Unknown Phase
Advanced Gastrointestinal Endoscopic Imaging
TerminatedNCT01034670
Start: 2009-06-30End: 2017-09-25Updated: 2024-06-26
Use of Fluorescein Dye for the Removal of Brain Tumors
CompletedNCT02389530
Start: 2015-05-31End: 2018-06-30Updated: 2018-08-03
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
WithdrawnNCT02540135
Start: 2015-03-01End: 2018-07-18Updated: 2018-07-20
Evaluation of Fluorescein Use During Cystoscopy
WithdrawnNCT02703558
Start: 2016-03-31End: 2018-01-10Updated: 2018-01-12
Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon
TerminatedNCT03220711
Start: 2017-07-28End: 2022-06-02Updated: 2022-11-22
Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy
TerminatedNCT03658551
Start: 2017-08-01End: 2020-08-01Updated: 2022-04-06
Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations
CompletedNCT04687488
Start: 2020-07-23End: 2020-11-09Updated: 2020-12-29
Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules
TerminatedNCT05556525
Start: 2023-05-12End: 2024-10-25Updated: 2025-09-17